These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16411142)

  • 1. Putting the chemo in chemoradiation for pancreatic cancer.
    Lowy AM
    Ann Surg Oncol; 2006 Feb; 13(2):135-6. PubMed ID: 16411142
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant therapy for pancreatic cancer: a time that has not yet come.
    Neifeld JP
    J Surg Oncol; 2007 Jun; 95(7):530-1. PubMed ID: 17192919
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer.
    Joensuu TK; Kiviluoto T; Kärkkäinen P; Vento P; Kivisaari L; Tenhunen M; Westberg R; Elomaa I
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):444-52. PubMed ID: 15380578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [IMRD therapy for patients with metastatic pancreas cancer].
    Yamashita K; Takahashi Y
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():219-22. PubMed ID: 16457254
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemoradiation for pancreatic adenocarcinoma].
    Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pancreatic cancer--diagnostics and therapy].
    Schramm H
    Zentralbl Chir; 2003 May; 128(5):367. PubMed ID: 12813632
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy in pancreatic cancer].
    Láng I
    Orv Hetil; 2004 Feb; 145(5):239-42. PubMed ID: 15024936
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer.
    Shivnani AT
    JAMA; 2007 Jun; 297(23):2581-2; author reply 2582. PubMed ID: 17579222
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head.
    Crane CH; Antolak JA; Rosen II; Forster KM; Evans DB; Janjan NA; Charnsangavej C; Pisters PW; Lenzi R; Papagikos MA; Wolff RA
    Int J Gastrointest Cancer; 2001; 30(3):123-32. PubMed ID: 12540024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer -- feasible and effective].
    Wilkowski R; Thoma M; Heinemann V; Rau HG; Wagner A; Stoffregen C; Dühmke E
    Strahlenther Onkol; 2003 Feb; 179(2):78-86. PubMed ID: 12590317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 Phase I trial.
    Girard N; Mornex F; Bossard N; Ychou M; Chauffert B; Wautot V
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1426-32. PubMed ID: 20056351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma.
    Budiharto T; Haustermans K; Van Cutsem E; Van Steenbergen W; Topal B; Aerts R; Ectors N; Bielen D; Vanbeckevoort D; Goethals L; Verslype C
    Radiat Oncol; 2008 Sep; 3():30. PubMed ID: 18808686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma.
    Duffy A; Kortmansky J; Schwartz GK; Capanu M; Puleio S; Minsky B; Saltz L; Kelsen DP; O'Reilly EM
    Ann Oncol; 2008 Jan; 19(1):86-91. PubMed ID: 17878176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of conformal radiotherapy and concurrent full-dose gemcitabine with erlotinib for unresected pancreatic cancer.
    Robertson JM; Margolis J; Jury RP; Balaraman S; Cotant MB; Ballouz S; Boxwala IG; Jaiyesimi IA; Nadeau L; Hardy-Carlson M; Marvin KS; Wallace M; Ye H
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e187-92. PubMed ID: 21549514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study.
    Brade A; Brierley J; Oza A; Gallinger S; Cummings B; Maclean M; Pond GR; Hedley D; Wong S; Townsley C; Brezden-Masley C; Moore M
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1027-36. PubMed ID: 17197132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma.
    Talamonti MS; Small W; Mulcahy MF; Wayne JD; Attaluri V; Colletti LM; Zalupski MM; Hoffman JP; Freedman GM; Kinsella TJ; Philip PA; McGinn CJ
    Ann Surg Oncol; 2006 Feb; 13(2):150-8. PubMed ID: 16418882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer.
    Ikeda M; Okada S; Tokuuye K; Ueno H; Okusaka T
    Br J Cancer; 2002 May; 86(10):1551-4. PubMed ID: 12085203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents.
    Pisters PW; Hudec WA; Lee JE; Raijman I; Lahoti S; Janjan NA; Rich TA; Crane CH; Lenzi R; Wolff RA; Abbruzzese JL; Evans DB
    J Clin Oncol; 2000 Feb; 18(4):860-7. PubMed ID: 10673529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoradiation protocols offer only incremental gains for pancreatic cancer patients.
    Bankhead C
    J Natl Cancer Inst; 2002 Nov; 94(22):1670-2. PubMed ID: 12441320
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I trial dosing of gemcitabine and concurrent involved field irradiation in patients with localized pancreatic carcinomas.
    Nanfro JJ
    J Clin Oncol; 1999 Nov; 17(11):3692. PubMed ID: 10550172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.